Lowe Brockenbrough & Co. Inc. lessened its stake in Markel Group Inc. (NYSE:MKL - Free Report) by 40.2% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,568 shares of the insurance provider's stock after selling 1,726 shares during the quarter. Lowe Brockenbrough & Co. Inc.'s holdings in Markel Group were worth $4,028,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also bought and sold shares of MKL. Boston Partners raised its position in Markel Group by 36.7% during the first quarter. Boston Partners now owns 214,400 shares of the insurance provider's stock valued at $326,124,000 after purchasing an additional 57,528 shares in the last quarter. Van Lanschot Kempen Investment Management N.V. raised its holdings in shares of Markel Group by 15.4% during the 2nd quarter. Van Lanschot Kempen Investment Management N.V. now owns 85,247 shares of the insurance provider's stock worth $134,320,000 after buying an additional 11,357 shares in the last quarter. International Assets Investment Management LLC raised its holdings in shares of Markel Group by 156,757.1% during the 3rd quarter. International Assets Investment Management LLC now owns 10,980 shares of the insurance provider's stock worth $17,223,000 after buying an additional 10,973 shares in the last quarter. Marshall Wace LLP bought a new stake in shares of Markel Group during the 2nd quarter worth $15,596,000. Finally, D. E. Shaw & Co. Inc. boosted its stake in Markel Group by 52.2% in the second quarter. D. E. Shaw & Co. Inc. now owns 22,341 shares of the insurance provider's stock valued at $35,202,000 after buying an additional 7,659 shares in the last quarter. Institutional investors own 77.12% of the company's stock.
Insider Buying and Selling at Markel Group
In related news, Director Lawrence A. Cunningham acquired 20 shares of the stock in a transaction dated Monday, August 5th. The stock was bought at an average cost of $1,512.50 per share, for a total transaction of $30,250.00. Following the completion of the transaction, the director now directly owns 743 shares of the company's stock, valued at $1,123,787.50. The trade was a 0.00 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 1.71% of the company's stock.
Markel Group Trading Up 0.2 %
MKL traded up $2.99 during trading on Friday, reaching $1,545.00. 68,666 shares of the company's stock were exchanged, compared to its average volume of 44,321. The company has a current ratio of 0.60, a quick ratio of 0.60 and a debt-to-equity ratio of 0.26. Markel Group Inc. has a one year low of $1,295.65 and a one year high of $1,670.24. The firm has a fifty day moving average price of $1,567.50 and a two-hundred day moving average price of $1,568.26. The stock has a market capitalization of $19.87 billion, a PE ratio of 7.13 and a beta of 0.73.
Markel Group (NYSE:MKL - Get Free Report) last issued its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $17.34 earnings per share for the quarter, missing the consensus estimate of $21.97 by ($4.63). The business had revenue of $3.69 billion during the quarter, compared to the consensus estimate of $3.74 billion. Markel Group had a return on equity of 10.86% and a net margin of 17.03%. As a group, equities research analysts forecast that Markel Group Inc. will post 91.55 earnings per share for the current fiscal year.
Analyst Ratings Changes
Several research analysts have commented on MKL shares. TD Cowen began coverage on Markel Group in a research note on Tuesday, July 9th. They set a "buy" rating and a $1,986.00 target price for the company. Citigroup upped their price objective on shares of Markel Group from $1,435.00 to $1,450.00 and gave the stock a "sell" rating in a research report on Tuesday, July 23rd. Jefferies Financial Group increased their price objective on shares of Markel Group from $1,590.00 to $1,600.00 and gave the company a "hold" rating in a research note on Wednesday, October 9th. StockNews.com cut shares of Markel Group from a "buy" rating to a "hold" rating in a research note on Monday, October 7th. Finally, Royal Bank of Canada dropped their price target on Markel Group from $1,700.00 to $1,675.00 and set a "sector perform" rating for the company in a research note on Friday. One analyst has rated the stock with a sell rating, five have given a hold rating and one has assigned a buy rating to the company. According to MarketBeat, Markel Group presently has an average rating of "Hold" and an average target price of $1,651.83.
View Our Latest Stock Report on Markel Group
About Markel Group
(
Free Report)
Markel Group Inc, a diverse holding company, engages in marketing and underwriting specialty insurance products in the United States, Bermuda, the United Kingdom, and Germany. The company offers general and professional liability, personal lines, marine and energy, specialty programs, and workers' compensation insurance products; and property coverages that include fire, allied lines, and other specialized property coverages, including catastrophe-exposed property risks, such as earthquake and wind.
Further Reading
Before you consider Markel Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Markel Group wasn't on the list.
While Markel Group currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.